跳至主要内容
临床试验/EUCTR2012-005198-30-ES
EUCTR2012-005198-30-ES进行中(未招募)不适用

EFFICACY OF ADMINISTRATION OF HYOSCINE BUTILBROMIDE (BUSCOPAN®) ON PREGNANT WOMEN IN FIRST STAGE OF LABOUR IN CASE OF CERVIX RIGIDITY. (BBH V.04-2013 EUDRACT: 2012-005198-30) - BUSCOPAN USE IN CERVIX RIGIDITY IN LABOUR

AURA TARRATS VELASCO0 个研究点开始时间: 2013年2月4日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • -Detection, by means of vaginal exploration, of cervical rigidity in first stage of labour
  • -18-40 year-old-pregnants
  • -cephalic position of fetus
  • -Term pregnancy
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 82
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • -Non-treated glaucoma.
  • -Taquicardia, miastenia gravis, paralitic ilium, mecanical estenose of
  • guts, megacolon, allergy or hipersensitivity to Buscopan.
  • -Treatment with: triciclic antidepressives, antihistamine drugs,
  • quinidina, amantadina, disopiramida, domapine antagonists, betaadrenergics
  • and others sucha as digoxine due to possible drug
  • interaction.
  • -previous cervical surgery
  • -Less than 30 min since last peridural anesthetics dose.

研究者

发起方
AURA TARRATS VELASCO

相似试验

SE OF BUSCOPAN AS AN EASIER OF FIRST STAGE OF LABOUR... | 临床试验